Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Blum

Showing results (241-250 of 336) with videos related to

Pageof 34
Sort By:
Advances in Therapy|July 19, 2008
The H-Wave device is an effective and safe non-pharmacological analgesic for chronic pain: a meta-analysisKenneth Blum, Amanda L C Chen, Thomas J H Chen, et al.
International Journal of Environmental Research and Public Health|September 28, 2021
Hypothesizing Nutrigenomic-Based Precision Anti-Obesity Treatment and Prophylaxis: Should We Be Targeting Sarcopenia Induced Brain Dysfunction?Kenneth Blum, Mark S Gold, Luis Llanos-Gomez, et al.
Acta Scientific Neurology|March 8, 2021
Should We Embrace the Incorporation of Genetically Guided "Dopamine Homeostasis" in the Treatment of Reward Deficiency Syndrome (RSD) as a Frontline Therapeutic Modality?Kenneth Blum, Ali Raza, Tiffany Schultz, et al.
International Journal of Environmental Research and Public Health|January 11, 2022
Hypothesizing in the Face of the Opioid Crisis Coupling Genetic Addiction Risk Severity (GARS) Testing with Electrotherapeutic Nonopioid Modalities Such as H-Wave Could Attenuate Both Pain and Hedonic Addictive BehaviorsAshim Gupta, Abdalla Bowirrat, Luis Llanos Gomez, et al.
Current Psychopharmacology|September 1, 2021
Endorphinergic Enhancement Attenuation of Post-traumatic Stress Disorder (PTSD) <i>via</i> Activation of Neuro-immunological Function in the Face of a Viral PandemicKenneth Blum, Edward J Modestino, David Baron, et al.
Advances in Therapy|October 20, 2006
Delayed P300 latency correlates with abnormal Test of Variables of Attention (TOVA) in adults and predicts early cognitive decline in a clinical settingEric R Braverman, Thomas J H Chen, John Schoolfield, et al.
Journal of Systems and Integrative Neuroscience|December 12, 2019
Death by Opioids: Are there non-addictive scientific solutions?B William Downs, Kenneth Blum, David Baron, et al.
Advances in Therapy|February 6, 2007
Reward deficiency syndrome in obesity: a preliminary cross-sectional trial with a Genotrim variantKenneth Blum, Thomas J H Chen, Brian Meshkin, et al.
Advances in Therapy|June 15, 2007
Gene \Narcotic Attenuation Program attenuates substance use disorder, a clinical subtype of reward deficiency syndromeThomas J H Chen, Kenneth Blum, Roger L Waite, et al.
International Journal of Spine Surgery|July 11, 2025
Opioid-Induced Hyperalgesia and Inflammaging in the Management of Spine Pain: The Case for Genetically Directed Dopamine HomeostasisKai-Uwe Lewandrowski, Rossano Kepler Alvim Fiorelli, Sergio Schmidt, et al.
Pageof 34

Showing results (241-250 of 336) with videos related to

Sort By:
Pageof 34
Advances in Therapy|July 19, 2008
The H-Wave device is an effective and safe non-pharmacological analgesic for chronic pain: a meta-analysisKenneth Blum, Amanda L C Chen, Thomas J H Chen, et al.
International Journal of Environmental Research and Public Health|September 28, 2021
Hypothesizing Nutrigenomic-Based Precision Anti-Obesity Treatment and Prophylaxis: Should We Be Targeting Sarcopenia Induced Brain Dysfunction?Kenneth Blum, Mark S Gold, Luis Llanos-Gomez, et al.
Acta Scientific Neurology|March 8, 2021
Should We Embrace the Incorporation of Genetically Guided "Dopamine Homeostasis" in the Treatment of Reward Deficiency Syndrome (RSD) as a Frontline Therapeutic Modality?Kenneth Blum, Ali Raza, Tiffany Schultz, et al.
International Journal of Environmental Research and Public Health|January 11, 2022
Hypothesizing in the Face of the Opioid Crisis Coupling Genetic Addiction Risk Severity (GARS) Testing with Electrotherapeutic Nonopioid Modalities Such as H-Wave Could Attenuate Both Pain and Hedonic Addictive BehaviorsAshim Gupta, Abdalla Bowirrat, Luis Llanos Gomez, et al.
Current Psychopharmacology|September 1, 2021
Endorphinergic Enhancement Attenuation of Post-traumatic Stress Disorder (PTSD) <i>via</i> Activation of Neuro-immunological Function in the Face of a Viral PandemicKenneth Blum, Edward J Modestino, David Baron, et al.
Advances in Therapy|October 20, 2006
Delayed P300 latency correlates with abnormal Test of Variables of Attention (TOVA) in adults and predicts early cognitive decline in a clinical settingEric R Braverman, Thomas J H Chen, John Schoolfield, et al.
Journal of Systems and Integrative Neuroscience|December 12, 2019
Death by Opioids: Are there non-addictive scientific solutions?B William Downs, Kenneth Blum, David Baron, et al.
Advances in Therapy|February 6, 2007
Reward deficiency syndrome in obesity: a preliminary cross-sectional trial with a Genotrim variantKenneth Blum, Thomas J H Chen, Brian Meshkin, et al.
Advances in Therapy|June 15, 2007
Gene \Narcotic Attenuation Program attenuates substance use disorder, a clinical subtype of reward deficiency syndromeThomas J H Chen, Kenneth Blum, Roger L Waite, et al.
International Journal of Spine Surgery|July 11, 2025
Opioid-Induced Hyperalgesia and Inflammaging in the Management of Spine Pain: The Case for Genetically Directed Dopamine HomeostasisKai-Uwe Lewandrowski, Rossano Kepler Alvim Fiorelli, Sergio Schmidt, et al.
Pageof 34